Celltrion to Present New Analyses of OMLYCLO® (omalizumab-igec) in Chronic Spontaneous Urticaria at ACAAI 2026 Post hoc analyses of the Phase 3 study of CT-P39 (omalizumab-igec) found… CISION PRNewswireNovember 12, 2026
Press Release ROYAL CARIBBEAN CELEBRATES LEGEND OF THE SEAS IN VETERANS DAY NAMING CEREMONY The vacation brand welcomed the Icon Class ship to Fort Lauderdale, Florida,… CISION PRNewswireNovember 12, 2026
DIAGENS Leads Medical AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets iMed-6.0 brings multimodal reasoning to medical imaging and powers a multi-task CT… CISION PRNewswireNovember 12, 2026
Press Release PROYA Debuts at Ulta Beauty, Bringing Science-Driven Prestige Skincare to U.S. Backed by a global R&D ecosystem and award-winning scientific research, Asia’s leading… CISION PRNewswireNovember 12, 2026
Press Release MSI MGA and Red Bull Reunite to Define a New Benchmark for Global Esports Official PC Partner for Red Bull Home Ground and Red Bull League… CISION PRNewswireNovember 12, 2026
Press Release Baidu Unveils Latest ERNIE Models Amid Broader Full-Stack AI Lineup, and Debuts Token Exchange to Power Intelligent Organizations Robin Li, Co-founder and CEO of Baidu, outlined his vision for the… CISION PRNewswireNovember 12, 2026
First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer SYDNEY, Nov. 12, 2026 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or… CISION PRNewswireNovember 12, 2026
ROLLER Accelerates the Shift to AI-Powered Venue Operations for the Attractions Industry New technology helps attraction operators unlock greater productivity and drive more efficient… CISION PRNewswireNovember 12, 2026